PHARMACYCLICS INC. / ABBVIE INC / Public / Acquisition / £13661m

Financials

Edit Data

Transaction Value£13,661m

Consideration Type-

Capital Owned-

Capital Bid For100%

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

Pharmacyclics Inc.

bidder

Abbvie

Sources

Edit

Tags

Edit

Acquisition

Public

Completed

Friendly

Single Bidder

Pharmaceuticals

pharmaceuticals

treatment development

cancer treatment

Biotechnology

small-molecula drugs

United States

Synopsis

Edit

Acquisition by AbbVie of Pharmacyclics, a biopharmaceutical company developing innovative products to treat cancer, atherosclerosis and other diseases.

PHARMACYCLICS INC. / ABBVIE INC / Public / Acquisition / £13661m

target

bidder

financial advisors

legal advisors

financial advisors